semaglutide-based treatments alternatives to tirzepatide Semaglutide and have dominated the pharma landscape over the past year, with drugs like Ozempic, Wegovy, Mounjaro, and Zepbound leading the way Novi GLP-1 Weight Loss Claims

Higher doses amplify the cortisol response without proportionally increasing GH output

The TRAVERSE trial, the first large randomized controlled study on testosterone replacement therapy, demonstrated that modest testosterone doses did not increase cardiovascular event risk in men aged 45-80

Ren Replace Ther 1:18

Eli Lilly is leading with a phase II trial initiated in early 2025 to evaluate mazdutide, a GLP-1/GIP dual agonist, in participants with AUD

Maintaining training intensity (the load on the bar relative to your max) is the primary signal that tells your body to preserve muscle

12 Ben-JonathanNMershonJLAllenDLSteinmetzRW